WO2023022671 - A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION

National phase entry is expected:
Publication Number WO/2023/022671
Publication Date 23.02.2023
International Application No. PCT/TR2021/050825
International Filing Date 18.08.2021
Title **
[English] A PROCESS FOR THE PREPARATION OF DRY POWDER COMPOSITIONS FOR INHALATION
[French] PROCÉDÉ DE PRÉPARATION DE COMPOSITIONS EN POUDRE SÈCHE POUR INHALATION
Applicants **
ARVEN ILAC SANAYI VE TICARET ANONIM SIRKETI
Inventors
CAN, Fatih
CELIK, Devrim
YILMAZ, Emine
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2146
EPO Filing, Examination, Granting11409
Japan Filing, Examination, Granting2325
South Korea Filing, Examination, Granting2261
USA Filing, Examination, Granting4740
MasterCard Visa
Total: 22,881

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Contact Us
Abstract[English] The invention relates to a process for the preparation of dry powder pharmaceutical compositions for inhalation. Further, the present invention also relates to dry powder pharmaceutical compositions administered by means of inhaler devices comprising ivermectin as an active agent and at least one pharmaceutically acceptable carrier.[French] L'invention concerne un procédé de préparation de compositions pharmaceutiques en poudre sèche pour inhalation. En outre, la présente invention concerne également des compositions pharmaceutiques en poudre sèche administrées au moyen de dispositifs inhalateurs comprenant de l'ivermectine en tant qu'agent actif et au moins un support pharmaceutiquement acceptable.

Rejoining the server...